[Bacteriological, pharmacokinetic and clinical studies on a rokitamycin dry syrup in the pediatric field]. 1988

Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
Department of Pediatrics, Jikei University School of Medicine.

Bacteriological, pharmacokinetic and clinical studies were done on the effect of rokitamycin (RKM, TMS-19-Q) in the field of pediatrics. The results are summarized below. 1. Antibacterial activities Antibacterial activities of RKM against Staphylococcus aureus (including 50 methicillin-sensitive and 50 methicillin-resistant strains), 18 strains of Haemophilus influenzae and 50 strains of Campylobacter jejuni were studied comparatively with activities of josamycin (JM), midecamycin (MDM), erythromycin (EM) and cefaclor (CCL) or ampicillin. Minimum inhibitory concentrations (MICs) of the 5 antibiotics against methicillin-sensitive S. aureus showed a wide variation but RKM was somewhat superior among them. MIC80 of those antibiotics tested against methicillin-sensitive S. aureus were as follows; RKM 1.56, JM 12.5, MDM 12.5, EM 6.25, and CCL 3.13 micrograms/ml. Among methicillin-resistant S. aureus (MRSA), ratios of strains highly resistant to these antibiotics (MIC greater than or equal to 100 micrograms/ml) to total number of strains tested were: 18% to RKM, and 26%, 34% and 48% to JM, MDM and EM, respectively, again showing the superiority of RKM and the proliferation of resistant organisms to EM. MICs of RKM against H. influenzae were distributed in a range between 0.78 and 12.5 micrograms/ml, which were similar to MIC range of CCL, and approximately twice as high as that of EM, but 4 folds lower than those of JM and MDM. Against C. jejuni, the MIC range of RKM was quite broad, 0.10-12.5 micrograms/ml, with a peak value of 0.20 micrograms/ml. The cumulative number of strains vs. MIC curve was similar to that of EM, and RKM was approximately 4 to 8 folds more effective than the other 3 antibiotics. 2. Absorption and excretion The absorption and the excretion of RKM were studied with its dry syrup preparations. Dose levels examined were 5 mg/kg in 2 cases, 10 mg/kg in 7 cases, 15 mg/kg in 2 cases and 20 mg/kg in 1 case. Peak concentrations of RKM in blood were not dose-dependent and were 0.16-0.23, 0.29-0.91, 0.35-0.46 microgram/ml and 0.53 microgram/ml, respectively, for the 4 dose levels. Most of drug levels dropped below the detection limit in 4 hours after the administration when dose levels up to 10 mg/kg were used, and when dose levels were at or above 15 mg/kg, 0.07-0.09 microgram/ml of RKM was detected in blood at 6 hours after the administration. Urinary recovery rates in 6 hours were between 0.19 and 3.31%.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007933 Leucomycins An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D008297 Male Males
D002168 Campylobacter fetus A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion. Spirillum fetus,Vibrio fetus
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D005260 Female Females
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
July 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
January 1995, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
June 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
July 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
July 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
June 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
July 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
July 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
June 1988, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and K Joh, and T Takahashi, and Y Watanabe, and M Hori
October 1988, The Japanese journal of antibiotics,
Copied contents to your clipboard!